Quotient Sciences
Drug Discovery · Biotechnology
Data updated Nov 22, 2026Full reportReport a mistake
Facts
as of Nov 22, 2026Quotient Sciences is a drug development & manufacturing accelerator. As a pharmaceutical CRDMO we support customers from candidate selection to commercial launch. Pharmaceutical CRDMO, Small Molecule Drug Development, Phase 1 Clinical Trials, Drug Manufacturing, Clinical Research.
- Employees
- 201-500estimated range
- Official records
- Wikidata Q140046011
- Website
- quotientsciences.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Products
Products →Quotient Sciences has 55 clinical trials on record, 5 under way.
Clinical trials
A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234
phase 1 · under way · 60 participants · as a collaborator · Healthy Participants
Nov 2026
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults
phase 1 · under way · 60 participants · as a collaborator · Friedreich Ataxia; Cardiomyopathies; Central Nervous System Diseases; Neuromusc…
Oct 2026
A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD4954 and the Absolut…
phase 1 · under way · 16 participants · as a collaborator · Healthy Participants
Oct 2026
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
Risk
Full record →Quotient Sciences: 80 research papers in five years.
No match
None
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
